In the S157 ecosystem, "DAC vs No-DAC" is not a technicality: it's a signal philosophy. The same molecule can produce completely different profiles depending on the exposure design - continuous ("bleed") versus pulsating (peaks). This article maps out what each approach tends to optimise (stability, convenience, smoothness) and what it tends to deteriorate (receiver sensitivity, causal clarity, tolerance). and what tends to deteriorate (receiver sensitivity, causal clarity, tolerance). At the end, I leave a mini-framework practical to read time profiles without confusion half-life with duration. To go deeper, cross with the Peptide Database, o Tactical Lexicon and Lab Tools.
1) Core concept - 2) Forms of exposure - 3) Desensitisation - 4) Examples (Database) - 5) Reading framework - Key Terms (Lexicon) - Related Database Profiles
1) Core concept: what "DAC" actually does
DAC (Drug Affinity Complex) is an engineering time. In simple terms: the design tries to "anchor" the molecule (often via affinity for albumin), creating a profile with:
- more stable exposure (fewer peaks and valleys);
- longer action window (often on a scale of days);
- less dependence on timing (convenience and consistency).
No-DAC (or "unanchored") maintains the more "native" behaviour of the signal: it tends to produce more defined wrists and a clearer temporal separation between "activation" and "silence".
In practice, DAC isn't "better" - it's an exchangeyou gain stability and lose some of the pulsatility that certain biological axes use as language.
DAC changes the question from "how much" to "how" - signal shape before magnitude. For a case study in your ecosystem, cross with CJC-1295 and with Research Journal (evidence framework).
2) Two forms of exposure: "pulses" vs "bleed" (continuous)
In S157, the critical difference is this:
- Pulsatingshort stimuli + real breaks → the receptor "breathes", resets and tends to maintain sensitivity.
- Continuous (bleed)prolonged stimulation → the receiver adapts, adjusts downwards and the system loses contrast.
Below is a high-level comparison. This is a map of trendswhat matters is which axis you're playing and what the language of that axis is - pulses or baseline.
| Dimension | DAC / "Bleed" (continuous) | No-DAC / Pulsatile | Typical risk |
|---|---|---|---|
| Signal shape | Smooth and persistent | Peaks + real silence | Receiver tolerance / saturation |
| Convenience | High (less dependence on timing) | Average (timing matters more) | Routine errors → causal noise |
| Causal clarity | It can dilute "effect vs cause" | Easier to map pulse response | Confusing half-life with duration |
| Compatibility with pulsating shafts | Sometimes "anti-physiological" | Tends to respect pulse physiology | Progressive desensitisation |
3) Desensitisation: where it starts (and how it manifests itself)
Desensitisation is the practical name for the system's adaptation to a persistent stimulus. It can occur via:
- downregulation (fewer receptors available on the membrane);
- decoupling of the receiver (the receiver "hears" less of the same signal);
- change of feedback (the body increases endogenous "brakes").
Point S157 is this: when the signal is almost constantThe system loses contrast. And without contrast, the body tends to treat the message as "background noise".
If biology uses peaks As a language, a continuous "bleed" can be a mistranslation - even if it "seems more stable".
How to notice the problem without self-deception:
- Decreasing effect without any obvious change in context.
- Flat response window (less difference between good and bad days).
- More subjective variability (because the system is "compensating").
For correct time reading, always use the trio: half-life (50% drop), onset (start) and duration (effect window). They are not synonyms. For concepts and definitions, you have shortcuts in Lexicon.
4) Practical examples (with Database links)
4.1 GH-axis (classic example of "pulses")
The GH axis is often cited because it operates with natural pulses. Here, the reading "DAC vs No-DAC" makes sense as signal shape (baseline vs pulses). In your system, use these profiles as anchors:
- CJC-1295 - a good case for discussing "prolongation" vs "pulsatility" in conceptual terms.
- GHRP-2 - GHRP-6 - useful examples for thinking about "peaks" and short windows (no instructions here).
- Ipamorelin - Hexarelin - additional contrast within the same axis.
The purpose of these links is compare languages (peaks vs baseline) and reduce narratives. For the "PK/PD" layer (onset/duration/half-life), use the Lab Tools and cross-references with Lexicon.
4.2 Metabolic (where "baseline" can be part of the goal)
In incretins/metabolism, the story may be different: many modern strategies seek to stable baseline and convenience. Examples you already have in your Database:
Here, the risk isn't "pulses vs baseline" per se - it's confusing pharmacokinetic stability with "zero adaptation". Adaptation exists; the difference is that target physiological and the objective can better tolerate continuous presence.
4.3 Short window (to reinforce "half-life ≠ duration")
Bremelanotide (PT-141) it's useful to remember that:
- a onset may be different from what intuition suggests;
- a perceived duration may exceed the plasma half-life (effects downstream);
- the context (central/peripheral) changes the temporal reading.
If the aim is to learn "signal shape", always document time and context. In S157 this connects directly to the trio: Half-life, Onset, Duration. (No instructions here; concepts and checks in Lab Tools.)
5) S157 mini-framework for reading time profiles (no common errors)
- Identify the axisIs it naturally pulsatile (e.g. GH-axis) or is a system where a stable baseline is acceptable/desired?
- Define the target's "languageDoes it respond better to contrast (peaks) or continuous presence?
- Separates PK from PDhalf-life (PK) is not duration (PD). An effect can persist via cascades downstream.
- Look for signs of adaptation: effect decreasing, response flattening, variability increasing.
- Reduces measurement noise: consistency of context and metrics before drawing conclusions (no "how-to").
- Validates material when applicableif the input is unreliable, the time profile becomes impossible to interpret (see COA Auditor).
Key Terms (Lexicon) - direct shortcuts
- DAC (Drug Affinity Complex / affinity for albumin)
- Pulsed vs Bleed (sign shape)
- Desensitisation (receiver adaptation)
- Half-life (PK)
- Onset (top)
- Duration (effect window)
- PK/PD (time map vs effect)
Tip: if a link doesn't pre-filter automatically, it's still useful as a "context shortcut" to open Lexicon on the right term.
Related Database Profiles (6)
To immediately link time theory to real profiles in your system:
References
- Reviews on peptide half-life extension strategies (e.g. albumin binding and half-life extension).
- Classic literature on receptor regulation (GPCR): desensitisation, internalisation and downregulation under persistent stimulation.
- Applied PK/PD texts: formal distinction between half-life (PK), onset and duration/effect (PD).
- Documentation and traceability where applicable: documentary verification and limits of inference (see also COA Auditor).
Safety Note (S157): Educational content. Does not constitute medical advice. For risk reduction principles and use of information, please consult the Information Use Policy.
